{
  "id": "fluvoxamine",
  "name_cn": "氟伏沙明",
  "name_en": "Fluvoxamine",
  "category": "SSRI",
  "tags": [
    "Sigma1激动",
    "强迫症",
    "相互作用多"
  ],
  "stahl_radar": {
    "labels": [
      "SERT",
      "Sigma1",
      "M1",
      "H1",
      "Alpha1"
    ],
    "values": [
      9.5,
      9.8,
      1,
      1,
      1
    ],
    "link_ids": [
      "sert",
      "sigma1",
      "m1",
      "h1",
      "alpha1"
    ]
  },
  "pearls": [
    {
      "title": "强迫症首选",
      "type": "success",
      "content": "最早获批用于强迫症的SSRI之一，对强迫思维和行为有较好的疗效。"
    },
    {
      "title": "Sigma-1受体激动剂",
      "type": "info",
      "content": "在SSRI中对Sigma-1受体亲和力最高，可能具有额外的改善认知和抗精神病协同作用。"
    },
    {
      "title": "药物相互作用之王",
      "type": "danger",
      "content": "强效抑制CYP1A2和CYP2C19。严禁与替扎尼定、雷美替胺合用。会显著升高咖啡因和茶碱的浓度，建议服药期间减少饮茶喝咖啡。"
    }
  ],
  "pk_data": {
    "half_life": "15h",
    "protein_binding": "80%",
    "metabolism": "CYP1A2 (强抑制), 2D6",
    "peak_time": "3-8h"
  },
  "market_info": {
    "price": "$",
    "insurance": "甲类医保",
    "pregnancy": "C类"
  },
  "wiki_content": "# 氟伏沙明 (Fluvoxamine)\n\n> 此药物尚无详细百科内容。请在此处添加详细信息。\n\n## 作用机制\n\n（待补充）\n\n## 临床应用\n\n（待补充）\n\n## 不良反应\n\n（待补充）"
}